The Role of JAK Inhibitors in the Management of Pediatric Patients with Atopic Dermatitis: PEDS23 Seminar-in-Depth
CME Seminar in Depth - May 6, 2023 2:35 PM EST
The Role of JAK Inhibitors in the Management of Pediatric Patients with Atopic Dermatitis
This activity is supported by an educational grant from Incyte.
At the completion of this activity, participants should be better able to:
Review the multiple inflammatory pathways in AD
Recall key data on the use of JAK inhibitors to manage AD in pediatric patients
Discuss strategies to improve the standard of care in pediatric AD with advanced therapies
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Institute for Continuing Healthcare Education and CMEsquared. The Institute is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
The Institute for Continuing Healthcare Education designates this live and enduring activity for a maximum of 0.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures & Disclaimers
The Institute discloses that all relevant conflicts have been satisfactorily mitigated.